Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review

[1] Gurses AP(2010)Using an interdisciplinary approach to identify factors that affect clinicians' compliance with evidence-based guidelines Crit Care Med 38 S282-S291

[2] Marsteller JA(2003)The quality of health care delivered to adults in the United States N Engl J Med 348 2635-2645

[3] Ozok AA(1999)Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1458-1465

[4] Xiao Y(2017)Assessment of guideline adherence and quality of care with routine outcome monitoring data Tijdschr Psychiatr 59 159-165

[5] Owens S(2018)Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018 Eur J Cancer 103 356-387

[6] Pronovost PJ(2013)Economic burden of cancer across the European union: a population-based cost analysis Lancet Oncol 14 1165-1174

[7] McGlynn EA(2010)AGREE II: advancing guideline development, reporting and evaluation in health care J Clin Epidemiol 63 1308-1311

[8] Asch SM(2015)A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: are recommendations sensitive to different global resources? Breast 24 309-317

[9] Adams J(2012)Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival–a retrospective multi-centre cohort study Breast Cancer Res Treat 132 1073-1080

[10] Keesey J(2010)Effects of guideline adherence in primary breast cancer–a 5-year multi-center cohort study of 3976 patients Breast 19 120-127

[1] Gurses AP(2010)Using an interdisciplinary approach to identify factors that affect clinicians' compliance with evidence-based guidelines Crit Care Med 38 S282-S291

[2] Marsteller JA(2003)The quality of health care delivered to adults in the United States N Engl J Med 348 2635-2645

[3] Ozok AA(1999)Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1458-1465

[4] Xiao Y(2017)Assessment of guideline adherence and quality of care with routine outcome monitoring data Tijdschr Psychiatr 59 159-165

[5] Owens S(2018)Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018 Eur J Cancer 103 356-387

[6] Pronovost PJ(2013)Economic burden of cancer across the European union: a population-based cost analysis Lancet Oncol 14 1165-1174

[7] McGlynn EA(2010)AGREE II: advancing guideline development, reporting and evaluation in health care J Clin Epidemiol 63 1308-1311

[8] Asch SM(2015)A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: are recommendations sensitive to different global resources? Breast 24 309-317

[9] Adams J(2012)Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival–a retrospective multi-centre cohort study Breast Cancer Res Treat 132 1073-1080

[10] Keesey J(2010)Effects of guideline adherence in primary breast cancer–a 5-year multi-center cohort study of 3976 patients Breast 19 120-127